Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy of Bisphosphonate Treatment in Young Adults Experiencing Fragility Fractures: A Population-Based Cohort Analysis

  • By

  • Sung Hye Kong

  • Ju-young Park

  • Moon-Kyung Shin

  • Hyo-Jung Lee

  • Jin Woo Kim

  • Seung Shin Park

  • Sang Wan Kim

  • Chan Soo Shin

  • Tae-Jin Song

  • December 6, 2024

Share

  • 1

    Bisphosphonate therapy significantly reduces the risk of major osteoporotic fractures in premenopausal women with a history of fragility fractures.

  • 2

    Ibandronate users experienced notable reductions in both major osteoporotic and nonvertebral fractures compared to nonusers.

  • 3

    Longer duration of bisphosphonate use (≥180 days) is associated with a significantly lower risk of subsequent fractures.

  • 4

    The study utilized a population-based cohort from South Korea, analyzing data from 2003 to 2014 to assess bisphosphonate efficacy.

  • 5

    Findings support considering bisphosphonates as a treatment option for premenopausal women at high risk of fractures.

Original Source(s)

Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study

  • by Sung Hye Kong, Ju-young Park, Moon-Kyung Shin, Hyo-Jung Lee, Jin Woo Kim, Seung Shin Park, Sang Wan Kim, Chan Soo Shin, Tae-Jin Song

  • December 6, 2024

Related Content

Higher Steroid Exposure Linked to Systemic Adverse Events in CRSwNP

Higher annual oral corticosteroid exposure was associated with greater odds of systemic adverse events, with avascular bone necrosis and pneumonia showing dose-dependent associations with cumulative dose and osteoporosis associated with longer annual exposure duration.

Bone Health and Fracture Prevention for Orthopedic Referrals

Baptist Health Orthopedic Care offers a Bone Health and Fracture Prevention Program for patients at increased risk of fracture who may benefit from early evaluation and treatment.

  • April 16, 2026

  • 2 min
Beyond Bone Density: How Fracture Risk Is Changing Osteoporosis Management

As osteoporosis treatment continues to evolve, clinicians are moving beyond bone mineral density scores alone and placing greater emphasis on fracture risk when making therapeutic decisions

  • by

  • July 8, 2026

  • 7 min